Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 2018; 392: 1995-2051
Investing in development: a practical plan to achieve the millennium development goals.
United Nations Development Programme,
New York, NY2005
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet. 2020; 396: 1160-1203
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet. 2014; 384: 1005-1070
Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.
BMC Infect Dis. 2010; 10: 109
Financing global health 2018: countries and programs in transition.
Institute for Health Metrics and Evaluation,
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet. 2020; 396: 1204-1222
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet. 2020; 396: 1250-1284
SDG Indicators—Global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development.
US health care spending by payer and health condition, 1996–2016.
JAMA. 2020; 323: 863-884
Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases.
New York, NY2018
Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals.
Lancet. 2018; 391: 2029-2035
Tracking the pharmaceutical pipeline: clinical trials and global disease burden.
Clin Transl Sci. 2014; 7: 297-299
Peering into the pharmaceutical “pipeline”: investigational drugs, clinical trials, and industry priorities.
Soc Sci Med. 2015; 131: 322-330
The biopharmaceutical pipeline: innovative therapies in clinical development.
Estimates of funding for various research, condition, and diseases categories (RCDC).
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global…
Read More News: Five insights from the Global Burden of Disease Study 2019